Rezolute (RZLT) Receivables - Other (2013 - 2023)

Rezolute's (RZLT) quarterly Receivables - Other came in at $400000.0 in Q3 2023, up 33.33% quarter-over-quarter from $300000.0 in Q2 2023.

Rezolute (RZLT) Receivables - Other (2013 - 2023) Analysis & Trends

Rezolute has disclosed Receivables - Other across 4 years of filings, most recently posting $400000.0 for Q3 2023.

Receivables - Other for Q3 2023 came in at $400000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $400000.0 (changed N/A YoY), and the FY2023 annual result was $300000.0, changed N/A from the prior year.
Receivables - Other came in at $400000.0 for Q3 2023 at Rezolute, up from $300000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $400000.0 in Q3 2023 to a low of $247000.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Rezolute	520.13 Mn	520.13 Mn	-

Download Data